LMATNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
LEMAITRE VASCULAR INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$82.31+1.49 (+1.84%)
Close on Oct 19, 2026
- Market cap
- $2.02B
- P/E (TTM)
- 28.9
- Dividend yield
- 0.97%
Lemaitre Vascular statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison
Valuation
| Measure | Lemaitre Vascular | Industry median |
|---|---|---|
| Market Cap | $1.88B | $229.23M |
| Enterprise Value | $1.51B | $194.73M |
| PE Ratio | 28.88 | 33.41 |
| PS Ratio | 7.17 | 3.14 |
| PB Ratio | 4.48 | 3.19 |
| P/TBV Ratio | 5.81 | 4.69 |
| P/FCF Ratio | 25.50 | 27.25 |
| P/OCF Ratio | 22.68 | 22.23 |
Enterprise value
| Measure | Lemaitre Vascular | Industry median |
|---|---|---|
| EV / Sales | 5.74 | 2.93 |
| EV / EBITDA | 17.15 | 19.97 |
| EV / EBIT | 19.48 | 25.47 |
| EV / FCF | 20.40 | 27.85 |
Income (trailing twelve months)
| Measure | Lemaitre Vascular | Industry median |
|---|---|---|
| Revenue | $262.43M | $102.39M |
| Gross Profit | $191.31M | $60.36M |
| Operating Income | $77.32M | -$4.31M |
| Pretax Income | $84.73M | -$2.26M |
| Net Income | $65.67M | -$6.57M |
| EBITDA | $87.82M | -$1.98M |
| EPS (Diluted) | $2.85 | -$0.07 |
Margins
| Measure | Lemaitre Vascular | Industry median |
|---|---|---|
| Gross Margin | 72.9% | 55.1% |
| Operating Margin | 29.5% | -6.04% |
| Pretax Margin | 32.3% | -4.11% |
| Profit Margin | 25.0% | -10.5% |
| EBITDA Margin | 33.5% | -2.67% |
| FCF Margin | 28.1% | -0.30% |
Returns
| Measure | Lemaitre Vascular | Industry median |
|---|---|---|
| Return on Equity (ROE) | 16.8% | -19.2% |
| Return on Assets (ROA) | 10.8% | -13.3% |
| Return on Invested Capital (ROIC) | 137.3% | -4.11% |
| Return on Capital Employed (ROCE) | 12.7% | -9.07% |
Growth
| Measure | Lemaitre Vascular | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 11.8% | 8.85% |
| Net Income Growth (YoY) | 39.4% | 10.6% |
| EPS Growth (YoY) | 38.3% | 10.6% |
| FCF Growth (YoY) | 41.1% | 10.6% |
| Revenue Growth (3Y CAGR) | 15.6% | 7.08% |
| Revenue Growth (5Y CAGR) | 14.0% | 11.8% |
| EPS Growth (3Y CAGR) | 39.4% | 3.06% |
| EPS Growth (5Y CAGR) | 19.4% | 7.64% |
Balance sheet
| Measure | Lemaitre Vascular | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $376.24M | $37.33M |
| Net Cash (Debt) | $376.24M | $3.92M |
| Net Cash Per Share | $16.45 | $0.28 |
| Equity (Book Value) | $420.34M | $57.36M |
| Book Value Per Share | $18.38 | $2.81 |
| Tangible Book Value | $323.85M | $10.71M |
| Working Capital | $458.36M | $54.64M |
Financial position
| Measure | Lemaitre Vascular | Industry median |
|---|---|---|
| Current Ratio | 16.31 | 2.50 |
| Quick Ratio | 13.76 | 1.54 |
| Interest Coverage | 14.88 | -1.81 |
Cash flow (trailing twelve months)
| Measure | Lemaitre Vascular | Industry median |
|---|---|---|
| Operating Cash Flow | $82.98M | -$653.46K |
| Capital Expenditures | -$9.15M | -$3.69M |
| Free Cash Flow | $73.83M | -$835.02K |
| FCF Per Share | $3.23 | -$0.02 |
Efficiency
| Measure | Lemaitre Vascular | Industry median |
|---|---|---|
| Asset Turnover | 0.43 | 0.59 |
| Revenue Per Employee | $400.66K | $322.75K |
| Profits Per Employee | $100.26K | -$52.11K |
| Employee Count | 655 | 197 |
Dividends and yields
| Measure | Lemaitre Vascular | Industry median |
|---|---|---|
| Earnings Yield | 3.49% | -6.92% |
| FCF Yield | 3.92% | -0.62% |
| Dividend Yield | 0.97% | 0.81% |
| Buyback Yield | 0.09% | 0.78% |
| Shareholder Yield | 1.06% | 0.84% |
| Dividend Per Share | $0.80 | $0.72 |
| Dividend Growth (YoY) | 25.0% | 4.80% |
| Years of Dividend Growth | 11 | 0 |
| Payout Ratio | 31.2% | 30.3% |
| FCF Payout Ratio | 27.8% | 21.9% |
Shares
| Measure | Lemaitre Vascular | Industry median |
|---|---|---|
| Shares Outstanding | 22,869,300 | 44,856,700 |
| Shares Change (YoY) | 3.66% | 3.35% |
| Shares Change (QoQ) | 0.08% | 0.27% |
| Float | 20,815,600 | 36,934,400 |
| Shares Held by Insiders | 8.98% | 10.6% |
| Shares Held by Institutions | 100.0% | 63.5% |
Taxes
| Measure | Lemaitre Vascular | Industry median |
|---|---|---|
| Income Tax | $19.06M | $1.52M |
| Effective Tax Rate | 22.5% | 18.6% |
Scores
| Measure | Lemaitre Vascular | Industry median |
|---|---|---|
| Graham Number | $34.33 | $34.37 |
| Graham Upside | -58.3% | -58.3% |
| Altman Z-Score | 7.25 | 1.95 |
| Piotroski F-Score | 6 | 5 |
| Beneish M-Score | -2.65 | -2.64 |
Calculated by StockData from Lemaitre Vascular's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.